Results 61 to 70 of about 357,928 (304)

An investigation of multidisciplinary complex health care interventions – steps towards an integrative treatment model in the rehabilitation of People with Multiple Sclerosis [PDF]

open access: yes, 2012
BackgroundThe Danish Multiple Sclerosis Society initiated a large-scale bridge building and integrative treatment project to take place from 2004–2010 at a specialized Multiple Sclerosis (MS) hospital.
Bjerre1, Liv   +6 more
core   +2 more sources

ALS With and Without Upper Motor Neuron Signs: A Comparative Study Supporting the Gold Coast Criteria

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The Gold Coast criteria permit diagnosis of amyotrophic lateral sclerosis (ALS) even without upper motor neuron (UMN) signs. However, whether ALS patients with UMN signs (ALSwUMN) and those without (ALSwoUMN) share similar characteristics and prognoses remains unclear.
Hee‐Jae Jung   +7 more
wiley   +1 more source

Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS

open access: yesJournal of Neuroinflammation, 2017
Background Laquinimod is an oral immunomodulator in clinical development to treat relapsing-remitting multiple sclerosis (RRMS). Laquinimod is in clinical development for the treatment of multiple sclerosis and Huntington Disease (HD).
Tjalf Ziemssen   +11 more
doaj   +1 more source

Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes. [PDF]

open access: yes, 2016
In patients who present with a clinically isolated syndrome (CIS), whose features are suggestive of multiple sclerosis (MS), fulfilling McDonald 2010 magnetic resonance imaging (MRI) criteria for dissemination in space (DIS) and dissemination in time ...
Altmann, Daniel R   +4 more
core   +1 more source

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein   +13 more
wiley   +1 more source

Guiding Multiple Sclerosis Care: An Update to the 2013 Consensus Statement from the MS in the 21st Century Steering Group

open access: yesNeurology and Therapy
Introduction In 2013, the “MS in the 21st Century” (MS21) initiative established a consensus statement for multiple sclerosis (MS) standards of care, with an overall vision including “Full access to personalised treatment, with reimbursement, to achieve ...
Raed Alroughani   +11 more
doaj   +1 more source

Heterogeneous Nuclear Ribonucleoprotein A1 Knockdown Alters Constituents of Nucleocytoplasmic Transport

open access: yesBrain Sciences
Background/Objectives: Changes in nuclear morphology, alterations to the nuclear pore complex (NPC), including loss, aggregation, and dysfunction of nucleoporins (Nups), and nucleocytoplasmic transport (NCT) abnormalities have become hallmarks of ...
Todd E. Stang   +4 more
doaj   +1 more source

Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry

open access: yesScientific Reports, 2021
In 2001, the German Multiple Sclerosis Society, facing lack of data, founded the German MS Registry (GMSR) as a long-term data repository for MS healthcare research.
Lisa-Marie Ohle   +10 more
doaj   +1 more source

Peripheral blood biomarkers in multiple sclerosis. [PDF]

open access: yes, 2015
Multiple sclerosis is the most common autoimmune disorder affecting the central nervous system. The heteroge-neity of pathophysiological processes in MS contributes to the highly variable course of the disease and unpre-dictable response to therapies ...
Acheson   +298 more
core   +1 more source

Social cognition in pediatric-onset multiple sclerosis (MS) [PDF]

open access: yesMultiple Sclerosis Journal, 2014
Background: Pediatric-onset multiple sclerosis (MS) patients represent a subpopulation who are diagnosed during the course of development. Social cognitive deficits have recently been recognized in adults with MS. It is critical to identify whether these youngest patients with the disorder are also at risk.
L E, Charvet   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy